ROSE WILLIAM - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 26, 2023, ROSE WILLIAM's relationship to REATA PHARMACEUTICALS INC (RETA) is Director, and currently has 0 shares of Class A common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RETA insiders.
Data Source: SEC.
ROSE WILLIAM - Insider Non-Derivative Transactions of RETA Class A common stock
ROSE WILLIAM - Insider Non-Derivative Transactions at RETA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 27, 2023 | Disposition -- (Class A common stock) | 180909 | 0 | 0 |
| Sep 27, 2023 | Disposition -- (Class A common stock) | 379281 | 0 | 0 |
| Sep 27, 2023 | Disposition -- (Class A common stock) | 11618 | 0 | 0 |
| Sep 27, 2023 | Disposition -- (Class A common stock) | 19795 | 0 | 0 |
| Sep 27, 2023 | Disposition -- (Class A common stock) | 7886 | 0 | 0 |
| Sep 27, 2023 | Disposition -- (Class A common stock) | 20 | 0 | 0 |
| Sep 27, 2023 | Disposition -- (Class A common stock) | 45 | 0 | 0 |
| Sep 27, 2023 | Disposition -- (Class A common stock) | 29 | 0 | 0 |
| Aug 24, 2023 | G -- (Class A common stock) | 500000 | 0 | 379281 |